Meerkats Pitchfork

Suddenly Meerkat comes out to put doubts into AHZ LTHs again.

i hear some of you guys say an 80% increase in income is not good enough and an increase of 320% income in 2016 isnt good enough...what a load of BS ... any company would gladly take that increase. They were talkin about 9 centres in Eur & Us each now its talk of 12 centres each and it is expanding every week with US surgeons themselves testing product and its uses on patients on site every day. Once they receive their bulk order it will boom out as word of mouth accross the world will sp[read as to the superiority of cardiocell and sudddenly a few audacious surgeons might try it out on aeortic and artetry repair or aneurisms or even the digestive tract repair and the use may treble overnight.

You detracters are not realising what a massive uptake and acceptance of such a new product this has been and the demand is outstripping supply by 99% - with the new factory a week old it can now start meeting demand and in the next 6 months the figures will outstrip Morgans estimates i reckon. Throw in Aus and Asia approvals and an increase in US and Eur centres to 20 each and then suddenly the income is much larger than morgans conservative estimates.

RBS Morgans estimates are well below Proactive brokers and Baillieu Holst's- you have ignored their projections for income and cardiocell are much higher. Morgans talkin down the short term income in 2015 but retaining their 23c TP is inconsistent and shows they arent too confident of this downgrade short term but they are confident of of 2016 tripling if income to $44M pa! So they are tellin us that it will take off but maybe not so quick but we wont reduce our TP because of it. This means they say outperform and BUY BUY while its cheap and while the cardiocell sales are low at the start, the ramp up in sales will cause the SP to move up 40$ short term and higher after that in 2016. You detracters are misreading this.

Meerkat was undermined last time he produced his pitchfork meerkat - his own pitchfork was moving up at a 30 degree angle with the mid fork crashed through at 14c and the top pitchfork clearly showing a TP of 19c-25c short term in the next 1-3 months yet he was talkin AHZ down at 12.5c saying it was topping out when it had broken the midfork resistance at 14c easily. Still no answer as to the triple top and he never called the 18.5c top as that may have been the best call at which to sell short term and then buy at 10c again.

Fact is that Meerkat and short traders like HSBC, Comsec have got AHZs moves totally wrong every time. buy at 5c-sell at 18.5c buy at 10c sell at 23c. What trader has got that pick right? no-one. Meerkat your pitchfork is a bullish sign and Morgans report is also a bullish sign as both show cardiocell sales light on now with SP cracking through midfork at 14c headed to 18.5c top again and brokers calling the triple top at 18.5c will be cracked through to 22-25c. From there the SP could go to that 55c that Baillieu Holst assess or Dr Tesla's 35c.

There is no bad news here- the question really is how high is this goin to go 18.5c? 23c? 55c? WHY SELL NOW then, its pointless, if they were downgrading and the 18.5c triple top held then maybe but not at 16c, the real action will be at 18-20c and then 22-25c where you short traders will take your lowly 50% gain whilst us investors like AF, Rowley, Catlow Rodne and Emichrome and myself stay in for that 1000% - 2000% as it hit with FMG and ANL before it. The old boys arent sellin here why should you?